PALB2 and breast carcinoma: Besides, two of the 12 (16.7%) PALB2 carriers were diagnosed with mixed invasive micropapillary carcinoma, an aggressive type of breast cancer with an unfavorable clinical prognosis (Middleton et al. 1999).